Physician

Amer Al-Khoudari, M.D.

According to 2025 Medicare claims, Amer Al-Khoudari, M.D. (NPI: 1013036516) practices rheumatology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is ARIZONA ARTHRITIS & RHEUMATOLOGY ASSOCIATES P C (NPI: 1366489254; TIN: 860765242) and primary practice location at 85225-2906. Al-Khoudari is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Al-Khoudari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 453 traditional Medicare patients, billed 187,169 HCPCS/CPT codes, and received $2,495,781 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,409 prescription claims across 356 beneficiaries totaling $1,298,930 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 369 records totaling $1,362,271. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $11,358 to $2,495,781. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,336 to $1,298,930. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	64	178	$11,358
2016	123	285	$22,490
2017	304	16,869	$298,974
2018	448	84,588	$954,932
2019	518	177,656	$1,755,360
2020	570	186,150	$2,276,735
2021	584	92,755	$1,475,252
2022	531	115,304	$1,512,736
2023	456	143,740	$1,503,227
2024	453	187,169	$2,495,781

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	34	74	$14,336
2016	69	191	$285,875
2017	189	1,004	$515,789
2018	313	1,512	$573,377
2019	381	1,842	$609,495
2020	387	1,988	$831,235
2021	372	1,546	$726,624
2022	366	1,446	$1,133,028
2023	371	1,401	$1,086,112
2024	356	1,409	$1,298,930

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	274	571	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	306	623	$12
80053	Blood test, comprehensive group of blood chemicals	232	513	$10
36415	Insertion of needle into vein for collection of blood sample	289	715	$9
85652	Red blood cell sedimentation rate, to detect inflammation, automated	185	409	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	26	896	$217,504
Rinvoq	Upadacitinib	20	720	$165,655
Orencia Clickject	Abatacept	22	728	$147,845
Enbrel Sureclick	Etanercept	13	364	$95,356
Cimzia (2 Pack)	Certolizumab Pegol	12	336	$68,849

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	354	$64,561	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	15	$1,297,710	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amer Al-Khoudari, M.D.?

Tedicare shows public-source Medicare data for Amer Al-Khoudari, M.D. (NPI 1013036516), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amer Al-Khoudari, M.D. have ACO affiliation data?

Amer Al-Khoudari, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Amer Al-Khoudari, M.D.?

Amer Al-Khoudari, M.D. is linked to ARIZONA ARTHRITIS & RHEUMATOLOGY ASSOCIATES P C (billing NPI 1366489254) in the available physician profile data.

Does Amer Al-Khoudari, M.D. have Open Payments data?

Amer Al-Khoudari, M.D. has 369 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.